cro.directory
← Compare landing

MMS Holdings vs Premier Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/mmsholdings/premier-research

CategoryMMS HoldingsPremier Research
Listed sitecrocro
SummaryData-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • Radiopharmaceutical
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Neurology
  • Rare Disease
  • Psychiatry
  • Infectious Disease
  • Oncology
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Dermatology
  • Women's Health
Locations
  • Global headquarters
  • Headquarters, Morrisville, NC, United States
  • Southbank, Southbank, VIC, Australia
  • Sofia, Sofia, Bulgaria
  • Toronto, Mississauga, ON, Canada
  • Prague, Praha, Czech Republic
  • Paris, Paris, France
  • Darmstadt, Darmstadt, Germany
  • Budapest, Budapest, Hungary
  • Bengaluru, Bengaluru, India
  • Auckland, Auckland, New Zealand
  • Warsaw, Warszawa, Poland
  • Bucharest, Bucharest, Romania
  • Bratislava, Bratislava, Slovakia
  • Seoul, Seoul, South Korea
  • Madrid, Madrid, Spain
  • Taipei, Taipei, Taiwan
  • Kyiv, Kyiv, Ukraine
  • Wokingham, Wokingham, Berkshire, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.